Sotabase

Career

· PhD Student in Learning and Adaptive Systems Group, ETH Zurich2024–
· Institute for Atmospheric and Climate Science, ETH Zurich
· Institute for Machine Learning, ETH Zurich
· Institute of Structural Engineering, ETH Zurich

Publications (14)

4-((R)-2-{[6-((S)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than Clopidogrel.
Journal of Medicinal Chemistry · 2015
46
cited
Cyclosporin A prodrugs: design, synthesis and biophysical properties.
Journal of Peptide Research · 2008
32
cited
Synthetic routes to NEtXaa4-cyclosporin A derivatives as potential anti-HIV I drugs
2000
30
cited
The reversible P2Y12 antagonist ACT‐246475 causes significantly less blood loss than ticagrelor at equivalent antithrombotic efficacy in rat
Pharmacology Research & Perspectives · 2017
29
cited
Conversion of cyclosporine A prodrugs in human tears vs rabbits tears.
European journal of pharmaceutics and biopharmaceutics · 2005
22
cited
Selatogrel, a reversible P2Y12 receptor antagonist, has reduced off-target interference with haemostatic factors in a mouse thrombosis model.
Thrombosis Research · 2021
15
cited
Efficient one‐pot synthesis of N‐ethyl amino acids
1999
12
cited
Water-soluble prodrugs of cyclosporine A with tailored conversion rates.
Journal of Peptide Research · 2005
7
cited
Discovery of novel bridged tetrahydronaphthalene derivatives as potent T/L-type calcium channel blockers.
Bioorganic & Medicinal Chemistry Letters · 2015
5
cited
Cyclosporine modifiee utilisable en tant que pro-drogue et son utilisation
2002
Ester salts (1R *, 2R *, 4R *) - 2- (2 - {[3- (4,7-dimethoxy-1H-benzoimidazole-2-yl) -propyl] -methyl-amino} -ethyl) - 5-phenyl-bicyclo [2.2.2] oct-5-en-2-yl ester
2009
Modified, applicable as a prodrug cyclosporin and its use
2002
New Synthetic Routes to NEtXaa4-Cyclosporin Derivatives as Potential Anti-HIV Drugs
2001
Selatogrel, the reversible and specific P2Y12 receptor antagonist, does not interfere with haemostasis
2020
Sotabase
Ferdinand Hübler | Researcher Profile | Sotabase | Sotabase